Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

NCT05636618

Conditions: Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
Locations: Mayo Clinic Jacksonville, Florida, United States

Biogenix Molecular Miami, Florida, United States

The University of Chicago Chicago, Illinois, United States

University of Iowa Iowa City, Iowa, United States

View all 19 locations

View Trial Details

Recruiting

Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma

NCT05281731

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.

NCT07586904

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Xijing Hospital, Air Force Medical University Xi'an, Shaanxi, China Xi'an, China

View Trial Details

Recruiting

Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma

NCT07586891

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Xijing Hospital, Air Force Medical University Xi'an, China

View Trial Details

Recruiting

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

NCT07485049

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations: St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View Trial Details

Recruiting

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

NCT05864534

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +11 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Recruiting

Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

NCT07584499

Conditions: Atypical Teratoid/Rhabdoid Tumors, Carcinoma, Carcinoma, Squamous Cell, +53 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Study of Mirdametinib in People With Central Nervous System Tumors

NCT07539441

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumors, Glioma, +10 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

NCT06528691

Conditions: CNS Tumor, Central Nervous System Neoplasms, Glioma, +11 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

Hospital de Câncer de Barretos Barretos, São Paulo, Brazil

GRAACC Hospital (Grupo de Apoio ao Adolescente e à Criança com Câncer) São Paulo, Brazil

Hospital Santa Marcelina São Paulo, Brazil

View Trial Details

Recruiting

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN

NCT06735560

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
Locations: CHU de Nantes Nantes, France

AP-HP - Site de Beaujon Paris, France

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions